Cargando…

999. Using the F/TDF Adherence-Efficacy Relationship to Calculate Background HIV incidence: Results from the DISCOVER trial

BACKGROUND: RRandomized trials of new PrEP agents compare to oral emtricitabine+tenofovir disoproxil fumarate (F/TDF) and do not have a placebo arm. We used the well-characterized adherence-efficacy relationship for F/TDF from iPrEX OLE, to back-calculate the (non-PrEP) background HIV incidence (bHI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Glidden, David V, Dunn, David T, Das, Moupali, Ebrahimi, Ramin, Zhong, Lijie, Stirrup, Oliver T, Anderson, Peter L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776424/ http://dx.doi.org/10.1093/ofid/ofaa439.1185

Ejemplares similares

Using the adherence‐efficacy relationship of emtricitabine and tenofovir disoproxil fumarate to calculate background hiv incidence: a secondary analysis of a randomized, controlled trial
por: Glidden, David V, et al.
Publicado: (2021)

995. Safety and Efficacy of F/TAF and F/TDF for PrEP in DISCOVER Participants Taking F/TDF for PrEP at Baseline
por: Campbell, Thomas, et al.
Publicado: (2020)

1288. Bone Safety Outcomes with F/TAF vs. F/TDF for PrEP in the DISCOVER Trial
por: Wohl, David, et al.
Publicado: (2019)

1962. Renal Outcomes for Participants Taking F/TAF vs. F/TDF for HIV PrEP in the DISCOVER Trial
por: Mills, Anthony, et al.
Publicado: (2019)

103. Persistence on F/TDF for HIV Pre-exposure Prophylaxis: Insights from Real-world Evidence
por: Tao, Li, et al.
Publicado: (2020)

855. Persistence on F/TAF versus F/TDF for HIV Pre-Exposure Prophylaxis: A Real-World Evidence Analysis in the United States
por: Tao, Li, et al.
Publicado: (2021)

866. Adherence to F/TDF for PrEP in Dried Blood Spots and HIV Infection Rates: A Pooled Analysis of Global PrEP Studies
por: Liu, Albert, et al.
Publicado: (2021)

999 : el último guardián /
por: Martigli, Carlo A.
Publicado: (2010)

Confidence limits for the averted infections ratio estimated via the counterfactual placebo incidence rate
por: Dunn, David T., et al.
Publicado: (2021)

Posters P788 - P999
Publicado: (2005)

Long-term efficacy and safety of E/C/F/TDF vs EFV/FTC/TDF and ATV+RTV+FTC/TDF in HIV-1-infected treatment-naïve subjects ≥50 years
por: Gazzard, Brian, et al.
Publicado: (2014)

985. Impact of Age and Medical Comorbidities on Renal Outcomes in the DISCOVER Trial
por: Daar, Eric, et al.
Publicado: (2020)

Interpretation of active-control randomised trials: the case for a new analytical perspective involving averted events
por: Dunn, David T., et al.
Publicado: (2023)

1298. Acquisition of TDF-Susceptible HIV Despite High Level Adherence to Daily TDF/FTC PrEP as Measured by Dried Blood Spot (DBS) and Segmental Hair Analysis: A Case Report
por: Cohen, Stephanie E, et al.
Publicado: (2018)

Usefulness of PET With [(18)F]LBT-999 for the Evaluation of Presynaptic Dopaminergic Neuronal Loss in a Clinical Environment
por: Ribeiro, Maria-Joao, et al.
Publicado: (2020)

999 The Role of Quantitative Blood PCR in the Management of Congenital Cytomegalovirus Infection
por: Leduc, Dorothée, et al.
Publicado: (2014)

Estimation of delay to diagnosis and incidence in HIV using indirect evidence of infection dates
por: Stirrup, Oliver T., et al.
Publicado: (2018)

Switching Tenofovir/Emtricitabine/Efavirenz (TDF/FTC/EFV) to TDF/FTC/Rilpivirine vs Continuing TDF/FTC/EFV in HIV-Infected Patients With Virological Suppression: A Randomized Controlled Trial
por: Wiriyatanakorn, Sirichai, et al.
Publicado: (2019)

TDF (Theoretical Domain Framework): how inclusive are TDF domains and constructs compared to other tools for assessing barriers to change?
por: Sarmast, Hamideh, et al.
Publicado: (2014)

The Icelandic founder mutation BRCA2 999del5: analysis of expression
por: Mikaelsdottir, Evgenia K, et al.
Publicado: (2004)

Prehospital recognition and antibiotics for 999 patients with sepsis: protocol for a feasibility study
por: Moore, Chris, et al.
Publicado: (2018)

Correction to: Toothpaste and mouthwash inactivate 99.9% of the virus that causes COVID-19
Publicado: (2021)

999. Nasal Mucosal Cytokines: Potential Biomarkers for Pediatric Pneumonia Severity and Etiology
por: Sayegh, Rouba, et al.
Publicado: (2021)

Adherence to daily, oral TDF/FTC PrEP during periconception among HIV-exposed South African women
por: Hurwitz, Kathleen E., et al.
Publicado: (2023)

The Story of the Dopamine Transporter PET Tracer LBT-999: From Conception to Clinical Use
por: Chalon, Sylvie, et al.
Publicado: (2019)

TDF(CAM): A method for estimating stable isotope trophic discrimination in wild populations
por: Johnson, Devin L., et al.
Publicado: (2023)

Mapping modifiable determinants of medication adherence in bipolar disorder (BD) to the theoretical domains framework (TDF): a systematic review
por: Prajapati, Asta Ratna, et al.
Publicado: (2021)

318. Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF) in Hispanic/Latinx and Black Participants: Efficacy, Bone and Renal Safety Results from a Pooled Analysis of 7 Clinical Trials
por: DeJesus, Edwin, et al.
Publicado: (2019)

Depression and Oral FTC/TDF Pre-exposure Prophylaxis (PrEP) Among Men and Transgender Women Who Have Sex With Men (MSM/TGW)
por: Defechereux, Patricia A., et al.
Publicado: (2015)

The effectiveness of TDF versus ETV on incidence of HCC in CHB patients: a meta analysis
por: Zhang, Zeyu, et al.
Publicado: (2019)

999. Ongoing Burden of Streptococcus pneumoniae Sepsis in Children After Introduction of Pneumococcal Conjuguate Vaccines
por: Asner, Sandra
Publicado: (2018)

Lisdexamfetamine Therapy in Paroxysmal Non‐kinesigenic Dyskinesia Associated with the KCNMA1‐N999S Variant
por: Keros, Sotirios, et al.
Publicado: (2021)

Using the Theoretical Domains Framework (TDF) to understand adherence to multiple evidence-based indicators in primary care: a qualitative study
por: Lawton, Rebecca, et al.
Publicado: (2016)

Re‐evaluation of Quillaia extract (E 999) as a food additive and safety of the proposed extension of use
por: Younes, Maged, et al.
Publicado: (2019)

Comparative gain-of-function effects of the KCNMA1-N999S mutation on human BK channel properties
por: Moldenhauer, Hans J., et al.
Publicado: (2020)

The Relationship of Throwing Arm Mechanics and Elbow Varus Torque: Within-subject Variation for Professional Baseball Pitchers Across 81,999 Throws
por: Dines, Joshua S., et al.
Publicado: (2017)

Background calculations for the ATLAS detector and hall
por: Battistoni, G, et al.
Publicado: (1994)

Comparison of the MARS and GCALOR background calculations
por: Talanov, V V, et al.
Publicado: (1999)

Genetically altered mice and cancer research: effects of the other 99.999% of the genome and other variables upon phenotype
por: Barthold, SW
Publicado: (2003)

Naïve patients receiving TDF/FTC-EFV as 2 pills are more likely to modify regimen components than patients receiving a TDF/FTC/EFV single pill
por: Perez-Valero, I, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_scl6pkdljc907grkkt99jj3a08